Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and peroxynitrite are highly reactive molecules that play dual roles in biological systems, acting as both essential signaling molecules and mediators of cellular damage [1][2]. ROS, such as superoxide and hydrogen peroxide, are primarily generated by the mitochondrial respiratory chain and enzymes like NADPH oxidases, while peroxynitrite is a potent oxidant formed by the rapid reaction of superoxide with nitric oxide [1]. Under physiological conditions, these species regulate processes like cell proliferation, differentiation, and the immune response [2]. However, an imbalance between their production and the body's antioxidant defenses leads to oxidative and nitrosative stress, which causes irreversible damage to DNA, lipids, and proteins [3]. This damage is a critical driver in the pathogenesis of chronic conditions, including cardiovascular diseases, neurodegenerative disorders like Alzheimer's, and various cancers [1][3]. Therapeutic interventions targeting these species include direct scavengers, such as edaravone and N-acetylcysteine, as well as catalytic mimetics of endogenous enzymes like superoxide dismutase [3]. Despite their potential, clinical success has been limited by the challenge of selectively neutralizing harmful levels of ROS/peroxynitrite without disrupting vital physiological signaling pathways [2][3]. Sources: [1] Pacher, P., et al. (2007) Physiological Reviews; [2] Sies, H., et al. (2017) Annual Review of Biochemistry; [3] Forman, H. J., & Zhang, H. (2021) Nature Reviews Drug Discovery.
Drugs targeting these species primarily function as chemical scavengers that directly neutralize reactive intermediates or as catalytic mimetics of endogenous antioxidant enzymes, such as superoxide dismutase, catalase, and glutathione peroxidase, to facilitate their conversion into stable, non-toxic molecules like water and oxygen [1][3].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and peroxynitrite (ROS/ONOO-).